RESUMEN
Sensenbrenner syndrome, or cranioectodermal dysplasia, is a rare heterogeneic autosomal recessive disorder, affecting ~1 of 1 000 000 live births. The syndrome usually manifests within the first year of life and can present with progressive liver and renal involvement. For all Sensenbrenner patients, renal and liver diseases are the main contributors of morbidity and mortality. In this report, we present the case of a 7-year-old boy with congenital liver disease progressing to liver failure secondary to Sensenbrenner syndrome. For this patient, evidence of liver dysfunction was evident from 2 months of age and progressed to frank cirrhosis and severe portal hypertension with multiple episodes of life-threatening variceal bleeding by age 6. This report illustrates the capability of orthotopic liver transplantation as a viable therapy for those pediatric patients suffering from severe liver failure secondary to a congenital ciliopathy, such as Sensenbrenner syndrome. In fact, early emphasis should be placed on the renal and liver involvement associated with Sensenbrenner syndrome with particular consideration for early referral for transplantation in cases with severe disease. Although the condition is rare, clinicians should be aware of it and its association with fatal liver disease to facilitate appropriate evaluation and referral.
Asunto(s)
Huesos/anomalías , Craneosinostosis/complicaciones , Displasia Ectodérmica/complicaciones , Fallo Hepático/cirugía , Trasplante de Hígado , Niño , Humanos , Fallo Hepático/congénito , MasculinoRESUMEN
Liver transplantation originated in children more than 50 years ago, and these youngest patients, while comprising the minority of liver transplant recipients nationwide, can have some of the best and most rewarding outcomes. The indications for liver transplantation in children are generally more diverse than those seen in adult patients. This diversity in underlying cause of disease brings with it increased complexity for all who care for these patients. Children, still being completely dependent on others for survival, also require a care team that is able and ready to work with parents and family in addition to the patient at the center of the process. In this review, we aim to discuss diagnoses of particular uniqueness or importance to pediatric liver transplantation. We also discuss the evaluation of a pediatric patient for liver transplant, the system for allocating them a new liver, and also touch on postoperative concerns that are unique to the pediatric population.
Asunto(s)
Enfermería de Cuidados Críticos , Trasplante de Hígado/métodos , Grupo de Atención al Paciente , Pediatría , Atresia Biliar/diagnóstico , Determinación de la Elegibilidad/normas , Enfermería de la Familia/métodos , Humanos , Fallo Hepático/congénito , Fallo Hepático/diagnóstico , Trasplante de Hígado/enfermería , Complicaciones PosoperatoriasRESUMEN
BACKGROUND: We had previously described a left lateral segment hyper-reduction technique capable of sizing the graft according to the volume of the abdominal cavity of the recipient. AIM: The purpose of our study was to evaluate our 14-year live-donor liver transplantation experience with in situ graft hyper-reduction in children under 10 kg of weight. PATIENTS AND METHODS: Between January 1997 and May 2011, we performed 881 liver transplants. Two hundred and seventy-seven (n = 277) involved pediatric recipients, of which 102 (37 %) were from live donors. Thirty-five (n = 35) patients under 10 kg of weight underwent hyper-reduced living donor liver transplants. There were 21 females (60 %) and 14 males (40 %), with a median age of 12 months (range 3-23) and a median weight of 7.7 kg (range 5.6-10). RESULTS: Median operative time was 350 min (range 180-510). Median cold ischemia time was 180 min (range 60-300). Twenty-six (n = 26) patients required intraoperative transfusion of blood products. There were 49 postoperative complications involving 26 patients (74 % morbidity rate). One-, 3-, and 5-year survival rates were 87, 79, and 74 %, respectively. Twenty-eight patients are currently alive. CONCLUSIONS: Hyper-reduced grafts provide an alternative approach for low-weight pediatric recipients. The relatively high immediate postoperative morbidity could be related to the complexity of these patients.
Asunto(s)
Peso Corporal , Fallo Hepático/cirugía , Trasplante de Hígado/métodos , Hígado/patología , Argentina , Femenino , Humanos , Terapia de Inmunosupresión/métodos , Lactante , Fallo Hepático/congénito , Donadores Vivos , Masculino , Tamaño de los Órganos , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/mortalidad , Tasa de Supervivencia , Recolección de Tejidos y Órganos/métodos , Ultrasonografía IntervencionalRESUMEN
OBJECTIVES: Although liver transplantation has been the standard of care therapy for life-threatening liver diseases for >20 years, data on the long-term impact of liver transplantation in children have been primarily limited to single-center experiences. The objective of this study was to characterize and evaluate the clinical course of children who have survived >or=5 years after pediatric liver transplantation in multiple centers across North America. PATIENTS AND METHODS: Patients enrolled in the Studies of Pediatric Liver Transplantation database registry who had undergone liver transplantation at 1 of 45 pediatric centers between 1996 and 2001 and survived >5 years from liver transplantation were identified and their clinical courses retrospectively reviewed. RESULTS: The first graft survival for 461 five-year survivors was 88%, with 55 (12%) and 10 (2%) children undergoing a second and third liver transplantation. At the 5-year anniversary clinic visit, liver function was preserved in the majority with daily use of immunosuppression therapy, including a calcineurin inhibitor and oral prednisone, reported by 97% and 25% of children, respectively. The probability of an episode of acute cellular rejection occurring within 5 years after liver transplantation was 60%. Chronic rejection occurred in 5% patients. Posttransplant lymphoproliferative disease was diagnosed in 6% children. Calculated glomerular filtration rate was <90 mL/minute per 1.73 m2 in 13% of 5-year survivors. Age- and gender-adjusted BMI>95th percentile was noted in 12%, with height below the 10th percentile in 29%. CONCLUSIONS: Children who are 5-year survivors of liver transplantation have good graft function, but chronic medical conditions and posttransplantation complications affect extrahepatic organs. A comprehensive approach to the management of these patients' multiple unique needs requires the expertise and commitment of health care providers both beyond and within transplant centers to further optimize long-term outcomes for pediatric liver transplant recipients.
Asunto(s)
Inmunosupresores/uso terapéutico , Fallo Hepático/cirugía , Trasplante de Hígado/efectos adversos , Sobrevivientes/estadística & datos numéricos , Niño , Preescolar , Femenino , Estudios de Seguimiento , Rechazo de Injerto , Supervivencia de Injerto , Humanos , Lactante , Estimación de Kaplan-Meier , Fallo Hepático/congénito , Fallo Hepático/mortalidad , Pruebas de Función Hepática , Trasplante de Hígado/mortalidad , Trasplante de Hígado/patología , Masculino , América del Norte , Pediatría/normas , Pediatría/tendencias , Probabilidad , Sistema de Registros , Estadísticas no Paramétricas , Factores de Tiempo , Trasplante HomólogoRESUMEN
Neonatal haemochromatosis (NH) is a severe and newly recognised syndrome of uncertain aetiology, characterised by congenital cirrhosis or fulminant hepatitis and widespread tissue iron deposition. NH occurs in the context of maternal disease including viral infection, as a complication of metabolic disease in the fetus, and sporadically or recurrently, without overt cause, in sibs. Although an underlying genetic basis for NH has been suspected, no test is available for predictive analysis in at risk pregnancies. As a first step towards an understanding of the putative genetic basis for neonatal haemochromatosis, we have conducted a systematic study of the mode of transmission of this disorder in a total of 40 infants born to 27 families. We have moreover carried out a molecular analysis of candidate genes (beta(2)-microglobulin, HFE, and haem oxygenases 1 and 2) implicated in iron metabolism. No pathogenic mutations in these genes were identified that segregate consistently with the disease phenotype in multiplex pedigrees. However, excluding four pedigrees with clear evidence of maternal infection associated with NH, a pedigree showing transmission of maternal antinuclear factor and ribonucleoprotein antibodies to the affected infants, and two families with possible matrilineal inheritance of disease in maternal half sibs, a large subgroup of the affected pedigrees point to the inheritance of an autosomal recessive trait. This included 14 pedigrees with affected and unaffected infants and a single pedigree where all four affected infants were the sole offspring of consanguineous but otherwise healthy parents. We thus report three distinct patterns of disease transmission in neonatal haemochromatosis. In the differentiation of a large subgroup showing transmission of disease in a manner suggesting autosomal recessive inheritance, we also provide the basis for further genome wide studies to define chromosomal determinants of iron storage disease in the newborn.
Asunto(s)
Hemocromatosis/congénito , Hemocromatosis/genética , Hierro/metabolismo , Fallo Hepático/congénito , Fallo Hepático/genética , Proteínas de la Membrana , Adolescente , Adulto , Orden de Nacimiento , Niño , Preescolar , Consanguinidad , Herencia Extracromosómica/genética , Resultado Fatal , Femenino , Antígenos HLA/genética , Haplotipos/genética , Hemo Oxigenasa (Desciclizante)/genética , Hemo-Oxigenasa 1 , Hemocromatosis/metabolismo , Hemocromatosis/fisiopatología , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Lactante , Recién Nacido , Fallo Hepático/metabolismo , Fallo Hepático/fisiopatología , Masculino , Intercambio Materno-Fetal/inmunología , Modelos Genéticos , Linaje , Embarazo , Complicaciones Infecciosas del Embarazo/inmunología , Complicaciones Infecciosas del Embarazo/metabolismo , Complicaciones Infecciosas del Embarazo/microbiología , Complicaciones Infecciosas del Embarazo/virología , Microglobulina beta-2/genéticaAsunto(s)
Hemocromatosis/diagnóstico , Fallo Hepático/diagnóstico , Terapia Combinada , Resultado Fatal , Femenino , Hemocromatosis/patología , Hemocromatosis/terapia , Humanos , Recién Nacido , Hígado/patología , Fallo Hepático/congénito , Fallo Hepático/patología , Fallo Hepático/terapia , Trasplante de Hígado , Masculino , Factores de TiempoRESUMEN
We report eight cases of portocaval anastomosis in infants diagnosed by ultrasound. Anatomically we believe this represents continuing patency of the ductus venosus, either as a primary developmental abnormality or secondary to established liver cell failure.